Category
Comparisons
5-Amino-1MQ vs SLU-PP-332: NNMT Inhibition and ERR Agonism Compared for Research
An NNMT inhibitor and a pan-ERR agonist, both small molecules and neither a peptide. Mechanisms, solubility, assay design and selection guidance for laboratory research.
AOD-9604 vs HGH Fragment 176-191: Cyclised and Linear Forms Compared for Research
Same growth-hormone segment, two chemical states. How the cyclised AOD-9604 differs from the linear hGH 176-191 fragment, and which to select for a given research design.
BPC-157 vs TB-500: Mechanism, Structure and Research Selection Compared
Two unrelated molecules grouped by convention, not biology. How BPC-157's angiogenic literature compares with TB-500's actin-binding mechanism for research selection.
Cagrilintide vs Semaglutide: Amylin Analog vs GLP-1 Agonist in Research
Cagrilintide is an amylin analog; semaglutide is a GLP-1 agonist. Different receptors, overlapping circuits — a research comparison and selection guide.
GHK-Cu vs AHK-Cu: Structure, Copper Chemistry, Research Areas and How to Choose
GHK-Cu and AHK-Cu differ by one residue but point at different literatures — matrix and skin models versus hair follicle work. A side-by-side research comparison.
Liraglutide vs Semaglutide: Acylation Chemistry, Half-Life and Research Selection
Same GLP-1 backbone, different acylation chemistry. How liraglutide's C16 palmitic design compares with semaglutide's C18 diacid for laboratory research selection.
Retatrutide vs Tirzepatide: Triple vs Dual Agonist Receptors and Research Selection
Retatrutide and tirzepatide share a GIP-based 39-residue scaffold; retatrutide adds glucagon receptor agonism. A side-by-side research comparison and selection guide.
Semaglutide vs Retatrutide: One Receptor vs Three in Metabolic Peptide Research
Semaglutide engages one receptor; retatrutide engages three. A side-by-side research comparison of structure, attribution, handling and how to pick between them.
Semaglutide vs Tirzepatide: Structure, Receptors and How to Choose a Research Standard
Semaglutide is a GLP-1 mono-agonist on a GLP-1 backbone; tirzepatide is a GIP-based dual GIP/GLP-1 agonist. A side-by-side research comparison and selection guide.
Survodutide vs Mazdutide: Dual GLP-1/Glucagon Agonists Compared for Research
Both hit the GLP-1 and glucagon receptors, but survodutide is a designed scaffold and mazdutide an oxyntomodulin analog. A receptor-balance comparison for research selection.
BPC-157 Capsules vs BPC-157 Vials: Format, Route and Research Selection
Same molecule, different format. How 500 mcg BPC-157 capsules compare with lyophilized vials on route, preparation variability, flexibility and traceability.
BPC-157 vs KPV: Repair Signalling and Anti-Inflammatory Signalling Compared
BPC-157 measures structural repair; KPV measures inflammatory signalling. Both appear in gut models for different reasons — a mechanism-led research selection guide.
CJC-1295 vs CJC-1295 with DAC: Maleimide Conjugation and Exposure Pattern Compared
One appended lysine and a maleimide linker separate these two GHRH analogs. How covalent albumin conjugation changes exposure pattern, handling and study design.
CJC-1295 vs Sermorelin: Native GHRH(1-29) and Its Substituted Analog Compared
Sermorelin is native GHRH(1-29); Modified GRF 1-29 is the same fragment hardened at four positions. What each substitution fixes, and which to use in a given design.
Ipamorelin vs GHRP-2: GHS-R1a Selectivity, Structure and Research Selection
Same ghrelin receptor, different selectivity profiles. How ipamorelin's clean GH response compares with GHRP-2's broader neuroendocrine reach for research selection.
KLOW Blend vs GLOW Blend: Composition, Molar Balance and Research Selection
KLOW is GLOW plus KPV. A composition-led comparison covering molar balance, attribution limits, copper-specific handling and when to buy components separately.
LL-37 vs Thymosin Alpha-1: Antimicrobial Effector and Immune Modulator Compared
One acts directly on microbial membranes, the other modulates T-cell and TLR signalling. A mechanism-led comparison of LL-37 and Thymosin Alpha-1 for research selection.